Chemotherapy-Free ‘Cancer Vaccine’ Moves From Mice to Human Trials at Stanford

A recent Stanford cancer study that cured 97 percent of mice from tumors has now moved on to soliciting human volunteers for a new cutting-edge medical trial. The trial is part of a gathering wave of research into immunotherapy, a type of treatment that fights cancer by using the body’s immune system to attack tumors.

Source: sfgate.com